DO

David W. Osborne

AB Arcutis Biotherapeutics: 23 patents #1 of 11Top 10%
VI Virotex: 8 patents #1 of 4Top 25%
CR Cruxcase: 8 patents #1 of 2Top 50%
AR Arcutis: 6 patents #1 of 1Top 100%
DS Dow Pharmaceutical Sciences: 5 patents #6 of 22Top 30%
ZC Zagg Intellectual Property Holding Co.: 2 patents #16 of 44Top 40%
NL Nlu Products, L.L.C.: 2 patents #4 of 10Top 40%
QU Qlt Usa: 1 patents #5 of 5Top 100%
TU The Upjohn: 1 patents #289 of 528Top 55%
TO Tolmar: 1 patents #3 of 10Top 30%
AL Atrix Laboratories: 1 patents #34 of 38Top 90%
AM AMD: 1 patents #5,683 of 9,279Top 65%
📍 Fort Collins, CO: #18 of 3,421 inventorsTop 1%
🗺 Colorado: #199 of 40,980 inventorsTop 1%
Overall (All Time): #30,586 of 4,157,543Top 1%
68
Patents All Time

Issued Patents All Time

Showing 1–25 of 68 patents

Patent #TitleCo-InventorsDate
12390453 Method for reducing side effects from administration of phosphodiesterase-4 inhibitors 2025-08-19
12336983 Inhibition of crystal growth of roflumilast 2025-06-24
12329751 Topical roflumilast formulation having antifungal properties David BERK, Patrick Eugene Burnett, Saori Kato 2025-06-17
12310956 Topical roflumilast formulation having improved delivery and plasma half-life 2025-05-27
12257242 Inhibition of crystal growth of roflumilast 2025-03-25
12220409 Roflumilast formulations with an improved pharmacokinetic profile 2025-02-11
12144802 Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug Babak N. TOFIG, Frank WATANABE 2024-11-19
12083122 Laureth-4 containing topical formulations 2024-09-10
12053481 Compositions and methods for deep dermal drug delivery Babak N. TOFIG 2024-08-06
12042558 Method and formulation for improving roflumilast skin penetration lag time 2024-07-23
12042487 Method for reducing side effects from administration of phosphodiesterase-4 inhibitors 2024-07-23
12016848 Roflumilast formulations with an improved pharmacokinetic profile 2024-06-25
12011437 Roflumilast formulations with an improved pharmacokinetic profile 2024-06-18
12005052 Topical roflumilast formulation having improved delivery and plasma half-life 2024-06-11
12005051 Topical roflumilast formulation having improved delivery and plasma half life 2024-06-11
11992480 Method for reducing side effects from administration of phosphodiesterase-4 inhibitors Howard Welgus 2024-05-28
11819496 Topical roflumilast formulation having improved delivery and plasma half-life 2023-11-21
11793796 Inhibition of crystal growth of roflumilast 2023-10-24
11730740 Laureth-4 containing topical formulations 2023-08-22
11707454 Topical roflumilast formulation having antifungal properties David BERK, Patrick Eugene Burnett, Saori Kato 2023-07-25
11628177 Compositions and methods for deep dermal drug delivery Babak N. TOFIG 2023-04-18
11534493 Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents 2022-12-27
11129818 Topical roflumilast formulation having improved delivery and plasma half life Bhaskar Chaudhuri, Archie W. THURSTON, JR. 2021-09-28
10940142 Inhibition of crystal growth of roflumilast 2021-03-09
10441530 Skin penetration enhancing systems for polar drugs Pramod Sarpotdar, Arturo Angel, Inigo Saenz de Tejada Gorman, Pedro Cuevas Sànchez 2019-10-15